Cannabis Short Sellers Now Down $473M In 2020 Following Tilray-Aphria Merger
After a brutal start to the year for cannabis investors, the ETF MANAGERS TR/TIERRA XP LATIN AME (NYSE:MJ) has rallied 36% in the past three months, propelled in large part by bullish U.S. election results in November.
The Numbers: Short sellers have aggressively piled into cannabis stocks in the past nine months, with cannabis stock short interest up about $1.15 billion to $2.81 billion since late March. The only good news for cannabis short sellers since March is that average stock borrow fees in the space have dropped from 30.3% to just 5%, according to S3 Partners analyst Ihor Dusaniwsky.
As of this week, Green Organic Dutchman Holdings Ltd (OTC:TGODF) is the most expensive cannabis stock to short with a 46.1% borrow fee.
Despite the recent rally, it hasn’t been all green for cannabis stocks this year. As of Wednesday, Aurora Cannabis Inc (NYSE:ACB) has been the most profitable short of the year in the cannabis group with Aurora short sellers sitting on a year-to-date profit of $123.8 million.
Consolidation Ahead? Cannabis short sellers have trimmed their year-to-date losses by $245.1 million so far in the month of December. However, thanks in part to the election, cannabis short sellers are still down $473.6 million overall in 2020.
Dusaniwsky said Wednesday that traders should watch the most shorted cannabis stocks for signs of a short squeeze, especially if the Tilray-Aphria merger marks the beginning of a consolidation wave in the industry.
“The underlying reasons for a short squeeze in the Cannabis sector were decreasing with the recent decrease in stock borrow costs and recent increase in mark-to-market profits, but the Tilray-Aphria merger may tighten the squeeze once again,” Dusaniwsky said.
The following are the five largest cannabis short positions as of Wednesday:
- Canopy Growth Corp (NASDAQ:CGC): $1.17 billion in short interest.
- GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH): $333.4 million in short interest.
- Aurora Cannabis: $325.2 million in short interest.
- Cronos Group Inc (NASDAQ:CRON): $318.9 million in short interest.
- Aphria: $236.9 million in short interest.
Benzinga’s Take: Cannabis stocks will likely continue to be volatile in the near term while the industry matures. Long-term investors should continue to monitor the progress ofU.S. state-by-state and federal legalization efforts given the U.S. market will likely be the biggest opportunity for the industry in coming years.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.